Drugmakers’ lobbying spending at 10-year high as Washington targets soaring prices By: MarketWatch May 02, 2019 at 13:49 PM EDT The spending by the industry’s main trade group and seven key drugmakers has climbed to a level not seen in a decade. Read More >> Related Stocks: AbbVie Astrazeneca Plc ADR Bristol-Myers Squibb Johnson & Johnson Merck & Co Pfizer Sanofi-Aventis S.A. ADR